首页> 外文期刊>BMC Infectious Diseases >Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda
【24h】

Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda

机译:乌干达临床分离株中分离出尿致原性大肠杆菌的生物膜形成,抗微生物敏感性和毒力基因

获取原文
           

摘要

INTRODUCTION:Uropathogenic E. coli is the leading cause of Urinary tract infections (UTIs), contributing to 80-90% of all community-acquired and 30-50% of all hospital-acquired UTIs. Biofilm forming Uropathogenic E. coli are associated with persistent and chronic inflammation leading to complicated and or recurrent UTIs. Biofilms provide an environment for poor antibiotic penetration and horizontal transfer of virulence genes which favors the development of Multidrug-resistant organisms (MDRO). Understanding biofilm formation and antimicrobial resistance determinants of Uropathogenic E. coli strains will provide insight into the development of treatment options for biofilm-associated UTIs. The aim of this study was to determine the biofilm forming capability, presence of virulence genes and antimicrobial susceptibility pattern of Uropathogenic E. coli isolates in Uganda.METHODS:This was a cross-sectional study carried in the Clinical Microbiology and Molecular biology laboratories at the Department of Medical Microbiology, Makerere University College of Health Sciences. We randomly selected 200 Uropathogenic E. coli clinical isolates among the stored isolates collected between January 2018 and December 2018 that had significant bacteriuria (?10sup5/sup?CFU). All isolates were subjected to biofilm detection using the Congo Red Agar method and Antimicrobial susceptibility testing was performed using the Kirby disk diffusion method. The isolates were later subjected PCR for the detection of Urovirulence genes namely; Pap, Fim, Sfa, Afa, Hly and Cnf, using commercially designed primers.RESULTS:In this study, 62.5% (125/200) were positive biofilm formers and 78% (156/200) of these were multi-drug resistant (MDR). The isolates were most resistant to Trimethoprim sulphamethoxazole and Amoxicillin (93%) followed by gentamycin (87%) and the least was imipenem (0.5%). Fim was the most prevalent Urovirulence gene (53.5%) followed by Pap (21%), Sfa (13%), Afa (8%), Cnf (5.5%) and Hyl (0%).CONCLUSIONS:We demonstrate a high prevalence of biofilm-forming Uropathogenic E. coli strains that are highly associated with the MDR phenotype. We recommend routine surveillance of antimicrobial resistance and biofilm formation to understand the antibiotics suitable in the management of biofilm-associated UTIs.
机译:介绍:尿鼠疗法大肠杆菌是泌尿道感染(UTI)的主要原因,占所有社区征收的80-90%,占所有医院收购UTI的30-50%。 Biofilm形成尿羟疗法大肠杆菌与持续和慢性炎症有关,导致复杂和或复发utis。生物膜为抗生素渗透和毒力基因的水平转移提供了一种抗性抗性生物(MDRO)的水平转移的环境。了解生物膜形成和抗菌致疗法大肠杆菌菌株的抗微生物抗性决定簇将深入了解生物膜相关utis的治疗方案的发展。本研究的目的是确定乌干达的毒力基因的存在,毒力基因的存在和抗菌大肠杆菌分离株的抗微生物敏感性模式。方法:这是在临床微生物学和分子生物学实验室进行的横截面研究Makerere大学健康科学医学微生物学系。我们在2018年1月至2018年1月至2018年12月间收集的储存分离株中随机选择了200次尿羟致疗法的大肠杆菌临床分离物,其具有显着的细菌(>?10 5 CFU)。使用刚果红琼脂法对所有分离物进行生物膜检测,并使用柯比磁盘扩散方法进行抗微生物易感性测试。分离株后来受到PCR的用于检测尿道血管基因; PAP,FIM,SFA,AFA,HLY和CNF,使用商业设计的底漆。结果:在本研究中,62.5%(125/200)是阳性生物膜成型剂,其中78%(156/200)这些是多药物抗性( MDR)。该分离物最耐受三甲硅烷嘧啶嘧啶和阿莫西林(93%),然后是庆大霉素(87%),最少是亚胺霉素(0.5%)。 FIM是最普遍的尿道尿素基因(53.5%),然后是PAP(21%),SFA(13%),AFA(8%),CNF(5.5%)和Hyl(0%)。结论:我们表现出高度普遍存在形成与MDR表型高相关的生物膜形成尿羟致原酚菌株。我们建议常规监测抗微生物抗性和生物膜形成,以了解适合于生物膜相关UXIS管理的抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号